372824005: Polymyxin B (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Antibacterial\Polymyxin (substance)\Polymyxin B (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Anti-infective agent (substance)\Antibacterial\Polymyxin (substance)\Polymyxin B (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Peptide\Cyclic peptide (substance)\Polymyxin (substance)\Polymyxin B (substance)

\Organic compound\Organic cyclic compound\Polycyclic compound (substance)\Cyclic peptide (substance)\Polymyxin (substance)\Polymyxin B (substance)
\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Peptide\Cyclic peptide (substance)\Polymyxin (substance)\Polymyxin B (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Polymyxin B (substance)	Is a	Polymyxin (substance)	true	Inferred relationship	Some
Polymyxin B (substance)	Is a	antibiotique cutané	false	Inferred relationship	Some
Polymyxin B (substance)	Is a	allergène médicamenteux	false	Inferred relationship	Some
Polymyxin B (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Antibacterial (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Polymyxin B sulfate ophthalmic agent	Is a	False	Polymyxin B (substance)	Inferred relationship	Some
Polymyxin B sulfate	Is a	False	Polymyxin B (substance)	Inferred relationship	Some
Polymyxin B sulfate otic agent	Is a	False	Polymyxin B (substance)	Inferred relationship	Some
Sulfomyxin	Is a	False	Polymyxin B (substance)	Inferred relationship	Some
Polymixin-B measurement	Component	True	Polymyxin B (substance)	Inferred relationship	Some	1
Polymyxin B adverse reaction	Causative agent (attribute)	True	Polymyxin B (substance)	Inferred relationship	Some	1
Allergy to polymyxin B	Causative agent (attribute)	False	Polymyxin B (substance)	Inferred relationship	Some
Polymyxin B eye ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B (substance)	Inferred relationship	Some
Polymyxin B eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B (substance)	Inferred relationship	Some
Polymyxin B sulfate+trimethoprim eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B (substance)	Inferred relationship	Some
Polymyxin B sulfate+bacitracin zinc eye ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B (substance)	Inferred relationship	Some
Polymyxin B sulfate+trimethoprim eye ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B (substance)	Inferred relationship	Some
Polymyxin B sulfate+bacitracin zinc 10,000u/500u ophthalmic ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B (substance)	Inferred relationship	Some
Dexamethasone + neomycin sulfate + polymyxin b sulfate 0.1%wv/3.5mg/10000unit ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B (substance)	Inferred relationship	Some
Dexamethasone + neomycin sulfate + polymyxin b sulfate 0.1%wv/3.5mg/10000unt suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B (substance)	Inferred relationship	Some
Gramicidin + neomycin sulfate + polymyxin b sulfate 0.025mg/1.75mg/10000unt solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B (substance)	Inferred relationship	Some
Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/1.6mg suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B (substance)	Inferred relationship	Some
Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/3.5mg/10000 unit suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B (substance)	Inferred relationship	Some
Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/7.5mg/10000unt suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B (substance)	Inferred relationship	Some
Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/7.5mg/1000unt solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B (substance)	Inferred relationship	Some
Hydrocortisone + polymyxin b 5mg/10000unt drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B (substance)	Inferred relationship	Some
Hydrocortisone acetate + neomycin sulfate + polymyxin b sulfate 5mg/3.5mg/10000unit cream	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B (substance)	Inferred relationship	Some
Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B (substance)	Inferred relationship	Some
Polymyxin b sulfate + trimethoprim sulfate 10000unt/1mg ophthalmic solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B (substance)	Inferred relationship	Some
Product containing polymyxin B (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B (substance)	Inferred relationship	Some	1
Product containing lidocaine and neomycin and polymyxin B (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B (substance)	Inferred relationship	Some	1
Product containing neomycin and polymyxin B and pramocaine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B (substance)	Inferred relationship	Some	1
Product containing bacitracin and neomycin and polymyxin B and pramocaine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B (substance)	Inferred relationship	Some	1
Product containing neomycin and polymyxin B (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B (substance)	Inferred relationship	Some	1
Product containing polymyxin B and trimethoprim (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B (substance)	Inferred relationship	Some	1
Product containing bacitracin and polymyxin B (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B (substance)	Inferred relationship	Some	1
Product containing polymyxin B in ophthalmic dosage form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B (substance)	Inferred relationship	Some
Product containing polymyxin B in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B (substance)	Inferred relationship	Some	1
Product containing polymyxin B in topical dosage form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B (substance)	Inferred relationship	Some
Polymyxin B-containing product in otic dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B (substance)	Inferred relationship	Some	1
Product containing polymyxin B in vaginal dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B (substance)	Inferred relationship	Some	1
Allergy to polymyxin B	Causative agent (attribute)	True	Polymyxin B (substance)	Inferred relationship	Some	1
Polymyxin B sulfate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Polymyxin B (substance)	Inferred relationship	Some
Product containing neomycin and polymyxin B and prednisolone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B (substance)	Inferred relationship	Some	2
Product containing dexamethasone and neomycin and polymyxin B (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B (substance)	Inferred relationship	Some	2
Product containing bacitracin and neomycin and polymyxin B (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B (substance)	Inferred relationship	Some	1
Product containing bacitracin and hydrocortisone and neomycin and polymyxin B (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B (substance)	Inferred relationship	Some	1
Product containing hydrocortisone and neomycin and polymyxin B (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B (substance)	Inferred relationship	Some	1
Product containing polymyxin B in ocular dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B (substance)	Inferred relationship	Some	1
Product containing polymyxin B in cutaneous dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B (substance)	Inferred relationship	Some	1
Bacitracin and neomycin and polymyxin B only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B (substance)	Inferred relationship	Some	1
Product containing only bacitracin and neomycin and polymyxin B and pramocaine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B (substance)	Inferred relationship	Some	1
Product containing only bacitracin and polymyxin B (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B (substance)	Inferred relationship	Some	1
Product containing only bacitracin and hydrocortisone and neomycin and polymyxin B (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B (substance)	Inferred relationship	Some	1
Dexamethasone and neomycin and polymyxin B only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B (substance)	Inferred relationship	Some	2
Neomycin and polymyxin B and pramocaine only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B (substance)	Inferred relationship	Some	1
Neomycin and polymyxin B and prednisolone only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B (substance)	Inferred relationship	Some	2
Hydrocortisone and neomycin and polymyxin B only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B (substance)	Inferred relationship	Some	1
Product containing only neomycin and polymyxin B (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B (substance)	Inferred relationship	Some	1
Lidocaine and neomycin and polymyxin B only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B (substance)	Inferred relationship	Some	1
Product containing only polymyxin B (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B (substance)	Inferred relationship	Some	1
Product containing only polymyxin B and trimethoprim (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B (substance)	Inferred relationship	Some	1
Polymyxin B only product in cutaneous dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B (substance)	Inferred relationship	Some	1
Polymyxin B only product in ocular dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B (substance)	Inferred relationship	Some	1
Polymyxin B only product in otic dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B (substance)	Inferred relationship	Some	1
Product containing only polymyxin B in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B (substance)	Inferred relationship	Some	1
Product containing only polymyxin B in vaginal dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B (substance)	Inferred relationship	Some	1
Polymyxin B (as polymyxin B sulfate) 500000 unit powder for solution for injection vial	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Polymyxin B (substance)	Inferred relationship	Some	1
Product containing only dexamethasone and neomycin and polymyxin B in ocular dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B (substance)	Inferred relationship	Some	2
Product containing precisely dexamethasone 1 milligram/1 milliliter and neomycin (as neomycin sulfate) 3500 unit/1 milliliter and polymyxin B sulfate 6000 unit/1 milliliter conventional release suspension for eye drops (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Polymyxin B (substance)	Inferred relationship	Some	2
Product containing precisely dexamethasone 1 milligram/1 milliliter and neomycin (as neomycin sulfate) 3500 unit/1 milliliter and polymyxin B sulfate 6000 unit/1 milliliter conventional release suspension for eye drops (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Polymyxin B (substance)	Inferred relationship	Some	2
Product containing dexamethasone and neomycin and polymyxin B in ocular dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Polymyxin B (substance)	Inferred relationship	Some	2

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1198119018	Polymyxin B (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1211344017	Polymyxin B	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
370901000195112	polimixina B	it	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
310011000077116	polymyxine B	fr	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
2414671000195118	Polymyxin B	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module